Company: SCAG
Filing Date: 2025-01-06
Form Type: 424B3
Source: 0001213900-25-001215
Chunk: 289

Company: Scage Future
Filing Date: 2025-01-06
Form: 424B3
Chunk 289
---
 of any entity or business. ValueScope did not undertake any independent analysis of any potential or actual litigation, regulatory action, possible unasserted claims or other contingent liabilities, to which Finnovate or Scage International was or may have been a party or was or may have been subject, or of any governmental investigation of any possible unasserted claims or other contingent liabilities to which Finnovate or Scage International was or may have been a party or was or may have been subject. 124 Conditions and Work Scope ValueScope’s opinions were necessarily based on financial, economic, market and other conditions as in effect on, and the information made available to ValueScope as of the date of its opinions. As Finnovate was aware, the credit, financial and stock markets may experience periods of unusual volatility resulting from “Black Swan” type events (e.g., the 2007 – 2008 credit market collapse or the Covid pandemic). ValueScope expressed no opinion or view as to any potential effects of such volatility on the Business Combination, and its opinions did not purport to address potential developments in any such markets. ValueScope did not undertake, and is under no obligation, to update, revise, reaffirm or withdraw its opinions, or otherwise comment on or consider events occurring or coming to its attention after the dates of its opinions. ValueScope was not requested to, and did not, (a) initiate or participate in any discussions or negotiations with, or solicit any indications of interest from, third parties with respect to the Business Combination, the securities, assets, businesses or operations of Finnovate, Scage International or any other party, or any alternatives to the Business Combination, (b) negotiate the terms of the Business Combination, (c) advise the Finnovate Board, Finnovate or any other party with respect to alternatives to the Business Combination, or (d) identify, introduce to the Finnovate Board, Finnovate or any other party, or screen for creditworthiness, any prospective investors, lenders or other participants in the Business Combination. ValueScope did not express any opinion as to what the value of the PubCo Ordinary Shares actually would be when issued in the Business Combination pursuant to the Business Combination Agreement or the price or range of prices at which Finnovate Ordinary Shares or PubCo Ordinary Shares could be purchased or sold, or otherwise be transferable, at any time. ValueScope’s opinions were furnished for the use of the Finnovate Board in its continued evaluation of the Business Combination. ValueScope